Option chain shows key data for Ellomay Cap's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Ellomay Cap.

Ellomay Cap (AMEX:ELLO) Stock, Option Chain

Ellomay Capital

Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

ARDS

ELLO

MRKR

PBLA

QTEK

VTGN

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 100 points on Wednesday.

The Dow traded down 0.34% to 32,929.04 while the NASDAQ fell 0.30% to 12,978.20. The S&amp;P 500, also fell, dropping, 0.39% to 4,189.27.

Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results

Movers

AMBI

ANGH

ARLO

BEST

BNOX

BSFC

DSEY

EDBL

EFOI

FRTX

Intelligent Bio Solutions Inc. - Common Stock

INBS

KBAL

LFST

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MESO

MIRO

NINE

NVOS

OBSV

RIGL

SFIX

SHLS

SNCR

SOUN

SVRE

SYTA

TMCI

TRKA

UNFI

VERX

VRAX

Gainers


	Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.


Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

APWC

CPSH

INFO

LIVE

PRVB

SYBX

Following the market opening Wednesday, the Dow traded up 0.08% to 31,093.91 while the NASDAQ rose 0.22% to 13,101.04. The S&amp;P also rose, gaining 0.07% to 3,803.73.

Mid-Morning Market Update: Markets Slightly Higher; IHS Markit Profit Beats Views

Ellomay Capital Ltd Ordinary Shares (Israel)

Ellomay Capital Ltd

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.03 per share. This is a 75 percent decrease over earnings of $0.12 per share from the same period last year. The company reported $12.07 million in sales this quarter. This is a 17.53 percent decrease over sales of $14.64 million the same period last year.

Ellomay Capital Q2 EPS $0.03 Down From $0.12 YoY, Sales $12.07M Down From $14.64M YoY

Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today announced a key achievement in its U.S. strategic growth plan. The Company has successfully entered into an agreement for the sale and transfer of Investment Tax Credits (ITCs) linked to its Fairfield (13.4 MW), Malakoff (13.92 MW), Mexia (11.1 MW), and Talco (10.5 MW) solar projects, all located in the State of Texas, USA. The agreement was executed with a reputable financial institution, with vast experience in executing tax credit transactions.
Through this transaction, the Company expects to receive approximately $19 million from the sale of Investment Tax Credits, representing approximately 32% of the expected total portfolio costs. The sale is facilitated under the Inflation Reduction Act's new transferability provisions, allowing Ellomay to retain 100% of the operating profits from these projects. Funds from the sale of the ITCs generated from a project will be disbursed after such project is placed in service and meets the applicable requirements. The Company expects the Fairfield and Malakoff projects to be placed in service by the end of Q4 2024, and the Mexia and Talco projects to be placed in service by the end of Q2 2025. The agreement includes customary indemnification obligations (for damages not covered by tax insurance policy), including in connection with certain continued eligibility requirements and scope of the ITCs, for which the Company provided a guarantee to the purchaser of the ITCs.

Asset Sales

Ellomay Capital Announces An Agreement For The Sale Of Investment Tax Credits From 4 Texas Solar Projects, Expecting To Receive About $19M, Representing 32% Of The Total Portfolio Costs, Under Provisions Allowing The Company To Retain All Operating Profits, With Project Completions Anticipated By Mid-2025

Ellomay  Reports Results Of Dorad Energy: Revenues For Three Months Ended June 30 Totals NIS659M, Operating Profit Totals NIS87.5M

Ellomay Capital Q1 EPS $(0.02) Down From $0.29 YoY, Sales $8.91M Down From $13.08M YoY

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly losses of $(0.56) per share. This is a 300 percent decrease over earnings of $0.28 per share from the same period last year. The company reported $9.32 million in sales this quarter. This is a 5.71 percent increase over sales of $8.81 million the same period last year.

Ellomay Capital Q4 EPS $(0.56) Down From $0.28 YoY, Sales $9.32M Up From $8.81M YoY

Ellomay Capital Ltd.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#NYSE">ELLO</a>) (TASE: ELLO) ("Ellomay" or the "Company"),&nbsp;a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel,&nbsp;today announced that it executed an agreement (the "Agreement") to sell its holdings in the 9 MW solar facility located in Talmei Yosef, Israel (the "Talmei Yosef Facility").
The Agreement provides for the sale of the Company's holdings in the Talmei Yosef Facility to Greenlight Fund Limited Partnership and Doral Group Renewable Energy Resources Ltd., in equal parts, in consideration for NIS 44.75 million (approximately $12.2 million), with an additional potential payment of up to NIS 4 million in the event the Talmei Yosef Facility will produce more than 18 million Kwh during 2024. The Agreement provides for a cutoff date of June 30, 2023 and the Company will be entitled to all revenues of the Talmei Yosef Facility up to such date, net of expenses for the period.
The Agreement includes customary representations and indemnification undertakings in connection with breaches of representations, which, other than with respect to customary exceptions, are subject to a cap of NIS 9 million and limited to a period of 18 months from the closing date.
The consummation of the sale is subject to various customary conditions to closing, including receipt of regulatory approvals and the consent of the financing entity of the Talmei Yosef Facility. All conditions to closing are required to be fulfilled within a period of 90 days from execution of the Agreement, which can be extended to up to 150 days under certain circumstances.
The Talmei Yosef Facility is located in southern Israel. One of the conditions to closing is the end of the war in southern Israel and that the Talmei Yosef Facility will be physically accessible. In addition, the Agreement provides that in the event that due to the current war and hostilities in Israel the facility will be damaged or its output will decrease, the buyers will have the right not to consummate the acquisition of the facility.
Following consummation of the sale, the Company will maintain the rights to the two projects under development located in the vicinity of the Talmei Yosef Facility: (i) a solar facility intended for 10 solar MW and 22 MW / hour batteries, and (ii) a battery storage facility intended for approximately 400 MW / hour.
As noted above, the consummation of the transactions contemplated by the Agreement is subject to the fulfilment of the conditions to closing, that are mostly not within the control of the Company or the buyers. There can be no assurance as to whether or when the conditions to closing will be satisfied and as to the impact of the war and hostilities in Israel on the ability to consummate the sale and on the final purchase price.

Ellomay Capital Enters Into An Agreement To Sell The Talmei Yosef Solar Facility To Greenlight Fund Limited Partnership And Doral Group Renewable Energy Resources Ltd., In Equal Parts, In Consideration For Approximately $12.2M

Ellomay Capital Says Does Not Expect Material Impact On The Timeline For Pumped Storage Project Construction In Israel

<a href="https://www.sec.gov/Archives/edgar/data/946394/000117891323003306/zk2330368.htm" title="https://www.sec.gov/Archives/edgar/data/946394/000117891323003306/zk2330368.htm">https://www.sec.gov/Archives/edgar/data/946394/000117891323003306/zk2330368.htm</a>

Ellomay Capital Says Construction Works In The Site Of Its Pumped Storage Project In The Manara Cliff, Israel Were Halted - Filing

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.12 per share. This is a 14.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $14.64 million in sales this quarter. This is a 21.22 percent decrease over sales of $18.58 million the same period last year.

Ellomay Capital Q2 EPS $0.12 Down From $0.14 YoY, Sales $14.64M Down From $18.58M YoY

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.29 per share. This is a 211.54 percent increase over losses of $(0.26) per share from the same period last year. The company reported $13.08 million in sales this quarter. This is a 0.27 percent increase over sales of $13.05 million the same period last year.

CORRECTION: Ellomay Capital Q1 EPS $0.29 Up From $(0.26) YoY, Sales $13.08M Up From $13.05M YoY

Ellomay Capital (AMEX:ELLO) reported quarterly earnings of $0.27 per share. This is a 203.85 percent increase over losses of $(0.26) per share from the same period last year. The company reported $12.03 million in salesEllomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.27 per share. This is a 203.85 percent increase over losses of $(0.26) per share from the same period last year. The company reported $12.03 million in sales this quarter. This is a 7.82 percent decrease over sales of $13.05 million the same period last year.

Ellomay Capital Q1 EPS $0.29 Up From $(0.26) YoY, Sales $13.08M Up From $13.05M YoY

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 100 points on Wednesday.
The Dow traded down 0.34% to 32,929.04 while the NASDAQ fell 0.30% to 12,978.20. The S&amp;P 500, also fell, dropping, 0.39% to 4,189.27.
Check This Out: <a href="https://www.benzinga.com/news/23/05/32646285/top-5-tech-and-telecom-stocks-that-are-flying-and-may-collapse"> Top 5 Tech And Telecom Stocks That Are Flying - And May Collapse</a>
&nbsp; 
<h3>Leading and Lagging Sectors</h3>
<ul>
<li>Utilities shares rose by 0.7% on Wednesday. Meanwhile, top gainers in the <a href='https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/'>sector</a> included Ellomay Capital Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ello#NYSE">ELLO</a>), up 8%, and Star Group, L.P. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sgu#NYSE">SGU</a>), up 4%.</li>
<li>In trading on Wednesday, energy shares dipped 1.8%.</li>
</ul>

&nbsp; 
<h3>Top Headline</h3>

Shares of Donaldson Co Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dci#NYSE">DCI</a>) dropped over 7% on Wednesday after the company reported third-quarter financial results and updated guidance.
Donaldson reported a sales increase of 2.6% Y/Y to $875.7 million beating the consensus of $868.4 million. EPS stood at 76 cents, up from 67 cents a year ago, exceeding the consensus of $0.74.
The company now expects FY23 adjusted EPS to be $3.00-$3.06 (vs $2.99-$3.07 previously) compared to the consensus of $3.04.
&nbsp; 
<h3>Equities Trading UP</h3>
<ul>
<li>Aridis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ards#NASDAQ">ARDS</a>) shares shot up 116% to $0.3991 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design.</li>
<li>Shares of Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) got a boost, shooting 32% to $1.7401 after the company reported pre-clinical data of its MT-601 multiTAA-specific T cell product candidate MT-601 in lymphoma cells.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) shares were also up, gaining 17% to $0.1567 after the company announced it will present fasedienol safety and exploratory efficacy data from its Phase 3 open-label social anxiety disorder study at the ASCP 2023 Annual Meeting.</li>
</ul>

&nbsp; 
<h3>Equities Trading DOWN</h3>
<ul>
<li>Advance Auto Parts, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aap#NYSE">AAP</a>) shares dropped 34% to $73.70 after the company reported worse-than-expected first-quarter financial results and cut FY23 guidance below estimates.</li>
<li>Shares of Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) were down 32% to $0.2298. Panbela announced a 1-for-30 reverse stock split effective June 1, 2023.</li>
<li>QualTek Services Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtek#NASDAQ">QTEK</a>) was down, falling 44% to $0.0842 after the company received Nasdaq delisting notice.</li>
</ul>

Also Check This Out: <a href="https://www.benzinga.com/news/23/05/32647354/amd-micron-and-2-other-stocks-insiders-are-selling"> AMD, Micron And 2 Other Stocks Insiders Are Selling</a>
&nbsp; 
<h3>Commodities</h3>

In commodity news, oil traded down 2% to $68.10 while gold traded up 0.3% at $1,983.50.
Silver traded up 1.5% to $23.59 on Wednesday while copper fell 0.7% to $3.6370.
&nbsp; 
<h3>Euro zone</h3>

European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 1.07%, London&rsquo;s FTSE 100 fell 1.01% while Spain&rsquo;s IBEX 35 Index fell 1.28% The German DAX slipped 1.54% French CAC 40 fell 1.54% and Italy&rsquo;s FTSE MIB Index fell 1.97%.
The annual inflation rate in Italy declined to 7.6% in May from 8.2% in the prior month, while GDP grew by 0.6% quarter-on-quarter during the three months to March 2023. Spain reported a current account surplus of &euro;5575 million in March, recording the highest surplus since July 2016.
The unemployment rate in Germany was steady at 5.6% during May. The French economy expanded 0.2% on quarter in the first quarter, while producer prices fell 5.1% month-over-month in April. The consumer price inflation in France dropped to 5.1 % year-over-year for May.
&nbsp; 
<h3>Asia Pacific Markets</h3>

Asian markets closed lower on Wednesday, with Japan&rsquo;s Nikkei 225 dropping 1.41%, Hong Kong&rsquo;s Hang Seng Index declining 1.94% and China&rsquo;s Shanghai Composite Index falling 0.61%. India&rsquo;s S&amp;P BSE Sensex fell 0.6%.
Japan&#39;s housing starts fell by 11.9% year-over-year in April versus aa 3.2% decline in the previous month, while consumer confidence index in Japan rose to 36 in May from 35.4 a month ago. Retail sales in Japan rose by 5% year-over-year in April, while industrial production fell by 0.4 % month-over-month during April.
The official NBS non-manufacturing PMI for China fell to 54.5 in May from 56.4 in the previous month, while official NBS manufacturing PMI declined to a five-month low level of 48.8 in May.
&nbsp; 
<h3>Economics</h3>
<ul>
<li>The Chicago PMI declined to 40.4 points in May versus 48.6 in April.</li>
<li>The number of job vacancies in the U.S. rose by 358 thousand to 10.1 million in April.</li>
</ul>

Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/05/32648620/bitcoin-drops-but-remains-above-this-key-level-optimism-conflux-among-top-losers"> Bitcoin Drops But Remains Above This Key Level; Optimism, Conflux Among Top Losers</a>
&nbsp; 
<h3>COVID-19 Update</h3>

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,107,490 cases with around 1,165,310 deaths. India confirmed a total of at least 44,990,580 cases and 531,870 deaths, while France reported over 40,081,380 COVID-19 cases with 167,310 deaths. In total, there were at least 689,549,940 cases of COVID-19 worldwide with more than 6,884,630 deaths.
&nbsp;

Ellomay Capital 2022 Revenues €53.4M

Ellomay Capital Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#NYSE">ELLO</a>) (TASE: ELLO)&nbsp;(&quot;Ellomay&quot; or the &quot;Company&quot;), a renewable energy and power generator and developer of renewable energy and power projects in&nbsp;Europe&nbsp;and&nbsp;Israel, today announced its entry into a Joint Development Agreement (the &quot;JDA&quot;) for the development of solar photovoltaic projects in the&nbsp;State of Texas.
The JDA was executed with a project development company experienced in the development of energy projects, site acquisition, capital markets and commercial management. The JDA provides for the initial development, design, construction and finance of two solar PV projects with aggregate projected DC capacity of 23 MW (the &quot;First Projects&quot;). The First Projects are in advanced stages of development and the estimated capital costs of the First Projects are in the range of&nbsp;$25-$27 million. The Company&#39;s share of the capital costs of the First Projects is estimated at approximately&nbsp;$18-$20 million&nbsp;and the balance is intended to be provided by tax equity sources with whom the Company is currently in discussions.&nbsp;The sites for the First Projects will be leased under long-term leases from special purpose companies (Landcos) controlled by the development team. &nbsp;One of the First Projects, with a DC capacity of approximately 13 MW, is expected to achieve Ready to Build status within six months. The JDA also provides for the development of three additional solar PV projects up to Ready to Build status with aggregate DC capacity of approximately 30 MW.
The projects to be developed under the JDA will be subject to the ERCOT Distributed Generation (&quot;DG&quot;) Scheme for projects of up to 10 MW AC capacity and the applicable electricity market is the &quot;ERCOT North&quot; zone market. Under the DG Scheme, ERCOT (the electricity regulator of the&nbsp;State of Texas), allows owners of generation assets to sell electricity to Qualified Service Entities (QSE&#39;s) at market rates under Real Time or Day Ahead prices at the local nodes where the projects are located and/or to designated &quot;Behind the Meter&quot; clients under Power Purchase Agreements.

Ellomay Capital Marks US Solar Photovoltaic Market Foray

<h3>Gainers</h3>
<ul>
<li>Kimball International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kbal#NASDAQ">KBAL</a>) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.</li>
<li>Fresh Tracks Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frtx#NASDAQ">FRTX</a>) rose 40.9% to $2.48 after the company announced, in its Phase 1 study, FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study&#39;s primary objectives.</li>
<li>Arlo Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/arlo#NYSE">ARLO</a>) gained 38% to $4.95 after the company reported better-than-expected Q4 results and issued FY23 adjusted EPS guidance above estimates.</li>
<li>Diversey Holdings, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dsey#NASDAQ">DSEY</a>) gained 37.3% to $8.16 after the company announced it will be acquired by Solenis for $4.6 billion.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) surged 37% to $4.15. Edible Garden announced Whole Foods Market plans to carry pulp line of gourmet sauces and chili-based products.</li>
<li>ObsEva SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/obsv#NASDAQ">OBSV</a>) shares jumped 34.6% to $0.1885 after dropping 30% on Tuesday.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/maxn#NASDAQ">MAXN</a>) shares climbed 34.2% to $25.17 after the company reported mixed Q4 financial results and issued guidance.</li>
<li>Fresh Tracks Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frtx#NASDAQ">FRTX</a>) gained 30.9% to $2.3050 after the company announced, in its Phase 1 study, FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study&#39;s primary objectives.</li>
<li>LifeStance Health Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lfst#NASDAQ">LFST</a>) gained 27% to $6.03 after the company reported mixed full year 2022 financial results and issued full year 2023 revenue guidance above estimates.</li>
<li>BEST Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/best#NYSE">BEST</a>) jumped 24.5% to $0.8098. BEST&rsquo;s board of directors has authorized a share repurchase program, under which BEST may repurchase up to $20 million worth of its shares.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmci#NASDAQ">TMCI</a>) gained 20.8% to $24.44 after the company reported better-than-expected Q4 financial results.</li>
<li>SaverOne 2014 Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svre#NASDAQ">SVRE</a>) gained 19.5% to $1.65 after the company announced it has signed an agreement with Electra Afikim to install the SaverOne system across its entire fleet of public buses, amounting to approximately 1,200 vehicles.</li>
<li>Rigel Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rigl#NASDAQ">RIGL</a>) rose 18.9% to $1.7472 after posting better-than-expected Q4 results.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose 18.8% to $3.60 after the company announced the FDA accepted its Biologics License Application resubmission for remestemcel-L in the treatment of children with steroid-refractory acute graft versus host disease.</li>
<li>Rigel Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rigl#NASDAQ">RIGL</a>) jumped 18% to $1.7350 after the company reported better-than-expected Q4 EPS and sales results.</li>
<li>Vertex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verx#NASDAQ">VERX</a>) gained 16.7% to $17.53 after the company reported better-than-expected Q4 results.</li>
<li>Membership Collective Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mcg#NYSE">MCG</a>) gained 16.6% to $7.30 after posting a profit for the fourth quarter.</li>
<li>Gol Linhas A&eacute;reas Inteligentes S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gol#NYSE">GOL</a>) rose 13% to $2.96 after the company reported Q4 financial results.</li>
<li>Rubicon Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbt#NYSE">RBT</a>) jumped 11.9% to $1.22.</li>
<li>OPKO Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opk#NASDAQ">OPK</a>) gained 9.9% to $1.1650 after the company announced its ModeX Therapeutics entered into an exclusive worldwide license and collaboration agreement with Merck for the development of MDX-2201.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) shares dipped 46.1% to $3.2314 after the company announced pricing of a $2.2 million public offering.</li>
<li>Miromatrix Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/miro#NASDAQ">MIRO</a>) fell 39.9% to $1.4850 after the company announced pricing of a $10 million public offering of common stock.</li>
<li>Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) fell 28.8% to $0.3990. Troika Media Group shares dropped around 27% on Tuesday after the company reported 1H financial results.</li>
<li>Emerg&ecirc;ncia Participa&ccedil;&otilde;es S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ambi#NYSE">AMBI</a>) dropped 27.4% to $9.76.</li>
<li>United Natural Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NYSE">UNFI</a>) fell 25.9% to $30.36 after the company reported worse-than-expected Q2 EPS and cut FY23 EPS guidance.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) dipped 24.2% to $5.25. The company recently posted worse-than-expected Q4 earnings and issued soft Q1 guidance. The company also announced it will acquire Weekend Health, Inc. for a net purchase price of $106 million.</li>
<li>Synchronoss Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sncr#NASDAQ">SNCR</a>) fell 22.5% to $0.79 following downbeat quarterly results.</li>
<li>Novo Integrated Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvos#NASDAQ">NVOS</a>) dipped 21.6% to $0.15.</li>
<li>Midatech Pharma plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtp#NASDAQ">MTP</a>) dropped 19.4% to $0.3969.</li>
<li>HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) fell 17.2% to $13.69. HUTCHMED (China) recently said FY22 sales results were higher year over year.</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) fell 16.7% to $0.1745.</li>
<li>Ellomay Capital Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ello#NYSE">ELLO</a>) dipped 14.7% to $10.44.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) fell 14.7% to $2.8415 after the company reported fourth-quarter financial results and issued guidance.</li>
<li>Stitch Fix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfix#NASDAQ">SFIX</a>) shares dropped 12.4% to $4.3450. Stitch Fix reported weaker-than-expected Q2 sales. The company is estimating Q3 revenue to come in a range of $385 million to $395 million, which would be a decline of 22% to 20% year-over-year.</li>
<li>Virax Biolabs Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrax#NASDAQ">VRAX</a>) shares fell 12.4% to $1.0601. Virax Biolabs shares gained 83% on Tuesday after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the European market..</li>
<li>Siyata Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syta#NASDAQ">SYTA</a>) fell 12% to $0.2287 after jumping over 32% on Tuesday.</li>
<li>Nine Energy Service, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nine#NYSE">NINE</a>) dropped 11.7% to $9.19 following Q4 results.</li>
<li>Bionomics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnox#NASDAQ">BNOX</a>) fell 10.9% to $3.86 after surging 20% on Tuesday.</li>
<li>Full House Resorts, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fll#NASDAQ">FLL</a>) dropped 10.2% to $8.92 following Q4 results.</li>
<li>HNI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hni#NYSE">HNI</a>) fell 9.4% to $27.11 after the company announced it will acquire Kimball International.</li>
<li>Anghami Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angh#NASDAQ">ANGH</a>) fell 9.1% to $2.09. Anghami recently reported a 35.6% revenue growth in preliminary unaudited 2022 results.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shls#NASDAQ">SHLS</a>) shares fell 7.7% to $24.52 after the company reported pricing of secondary offering of 24,501,650 shares of Class A common stock at a price of $24.70 per share by selling stockholders.</li>
<li>Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) fell 7.3% to $0.62 after gaining more than 28% on Tuesday.</li>
<li>Mercurity Fintech Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mfh#NASDAQ">MFH</a>) shares dropped 7% to $1.2001 after jumping over 43% on Tuesday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/03/31257106/insiders-selling-robinhood-and-3-other-stocks"> Insiders Selling Robinhood And 3 Other Stocks</a>

Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly losses of $(0.26) per share. This is a 36.84 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $13.05 million in sales this quarter. This is a 50.29 percent increase over sales of $8.68 million the same period last year.

Ellomay Capital Q1 EPS $(0.26) Down From $(0.19) YoY, Sales $13.05M Up From $8.68M YoY

TEL-AVIV, Israel,&nbsp;June 14, 2022&nbsp;/PRNewswire/ --&nbsp;Ellomay Capital Ltd.&nbsp;&nbsp;(NYSE American:&nbsp;ELLO) (TASE: ELLO)&nbsp;(&quot;Ellomay&quot; or the &quot;Company&quot;),&nbsp;a renewable energy and power generator and developer of renewable energy and power projects in&nbsp;Europe&nbsp;and Israel,&nbsp;today announced that the photovoltaic plant constructed by Ellomay Solar S.L., a wholly-owned subsidiary of the Company (&quot;Ellomay Solar&quot;), in the municipality of Talav&aacute;n, C&aacute;ceres,&nbsp;Spain, with a peak capacity of 28MW, was connected to the electricity grid and electricity production commenced. In parallel, hot commissioning tests have been initiated by the EPC contractor and PAC is currently expected on or about&nbsp;June 24, 2022.

General

Ellomay Capital Announces Successful Connection Of Ellomay Solar Photovoltaic Plant To Spanish Electricity Grid

Ellomay Capital FY21 Sales €44.8M, Up From €9.6M YoY

Ellomay Capital Announces Entry Into A Facilities Agreement By Talasol Solar

&nbsp;Ellomay Capital Ltd.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#NYSE">ELLO</a>) (TASE: ELLO)&nbsp;(&quot;Ellomay&quot; or the &quot;Company&quot;), a renewable energy and power generator and developer of renewable energy and power projects in&nbsp;Europe&nbsp;and&nbsp;Israel, today reported the publication in&nbsp;Israel&nbsp;of financial statements for the three and nine months ended&nbsp;September 30, 2021&nbsp;of Dorad Energy Ltd. (&quot;Dorad&quot;), in which Ellomay currently indirectly holds approximately&nbsp;9.4%&nbsp;through its indirect&nbsp;50%&nbsp;ownership of U. Dori Energy Infrastructures Ltd. (&quot;Dori Energy&quot;).
On&nbsp;November 23, 2021, Amos Luzon Entrepreneurship and Energy Group Ltd. (f/k/a U. Dori Group Ltd.) (the &quot;Luzon Group&quot;), an Israeli public company that currently holds the remaining&nbsp;50%&nbsp;of Dori Energy, which, in turn, holds&nbsp;18.75%&nbsp;of Dorad, published its quarterly report in&nbsp;Israel&nbsp;based on the requirements of the Israeli Securities Law, 1968. Based on applicable regulatory requirements, the quarterly report of the Luzon Group includes the financial statements of Dorad for the same period.
The financial statements of Dorad for the quarter ended&nbsp;September 30, 2021&nbsp;were prepared in accordance with International Financial Reporting Standards. Ellomay will include its indirect share of these results (through its holdings in Dori Energy) in its financial results for this period.&nbsp; In an effort to provide Ellomay&#39;s shareholders with access to Dorad&#39;s financial results (which were published in Hebrew), Ellomay hereby provides a convenience translation of Dorad&#39;s financial results.
Dorad Financial Highlights
<ul>
<li>Dorad&#39;s unaudited revenues for the three months ended&nbsp;September 30, 2021&nbsp;- approximately&nbsp;NIS 642.4 million.</li>
<li>Dorad&#39;s unaudited operating profit for the three months ended&nbsp;September 30, 2021&nbsp;- approximately&nbsp;NIS 130 million.</li>
</ul>
Dorad&#39;s financial statements for the three and nine months ended&nbsp;September 30, 2021&nbsp;note that following the outbreak of the coronavirus (COVID-19) in&nbsp;China&nbsp;in&nbsp;December 2019, and the spreading of the coronavirus to many other countries in early 2020, there has been a decline in economic activity in many regions of the world, as well as in&nbsp;Israel. The spreading of the coronavirus caused, among other things, a disruption in the supply chain, a decrease in global transport volume, traffic and employment restrictions declared by the Israeli government and other governments around the world, as well as declines in the value of financial assets and commodities in markets in&nbsp;Israel&nbsp;and around the world. Dorad notes that throughout this period and up to the reporting date it operated in compliance with, and according to, with the guidelines of the Israeli Ministries of Energy and Health on dealing with the coronavirus epidemic, including preparations of the operation and maintenance employees of the power plant and shift work as required. Dorad&#39;s financial statements further note that in light of the crisis, there is a certain decrease, which moderated during the period of the financial statements, in the electricity consumption of various customers, and there is also a certain decrease in the demand of the Israel Electric Company, and accordingly such reduction has not resulted in a material adverse effect at this time. Dorad notes that it is monitoring the re-spread of the virus and continuously examines its potential options for handling the impact to its income.
Based on the information provided by Dorad, the demand for electricity by Dorad&#39;s customers is seasonal and is affected by, inter alia, the climate prevailing in that season. The months of the year are split into three seasons as follows: the summer season &ndash; the months of July and August; the winter season - the months of December, January and February; and intermediate seasons &ndash; (spring and autumn), the months from March to June and from September to November. There is a higher hourly&nbsp;demand for electricity during the winter and summer seasons, and the average electricity consumption per hour is higher in these seasons than in the intermediate seasons and is even characterized by peak demands due to extreme climate conditions of heat or cold. In addition, Dorad&#39;s revenues are affected by the change in load and time tariffs - TAOZ (an electricity tariff that varies across seasons and across the day in accordance with demand hour clusters), as, on average, TAOZ tariffs are higher in the summer season than in the intermediate and winter seasons.&nbsp;Therefore, the results presented for the quarter ended&nbsp;September 30, 2021, which include the summer months of July and August and the intermediate month of September, are not indicative of full year results. In addition, due to various reasons, including the effects of the spread of Covid-19 and the economic impact of such spread and of actions taken by governments and authorities, the results included herein may not be indicative of&nbsp;third quarter&nbsp;results in the future.
A translation of the financial results for Dorad as of and for the year ended&nbsp;December 31, 2020&nbsp;and as of and for the three and nine month periods ended&nbsp;September 30, 2020&nbsp;and 2021 is included at the end of this press release.&nbsp;Ellomay does not undertake to separately report Dorad&#39;s financial results in a press release in the future. Neither Ellomay nor its independent public accountants have reviewed or consulted with the&nbsp;Luzon Group, Dori Energy or Dorad with respect to the financial results included in this press release.

Ellomay Capital 9.4% Stake Of Dorad Energy Reports For 3 Months Ending Sept. 30 Revenue NIS 642.4M

Ellomay (ELLO) has released an update. Ellomay Capital Ltd. has announced the successful private placement of its Series F Debentures, raising NIS ...

Ellomay Capital Raises NIS 50 Million from Debenture Sale

Ellomay (ELLO) has released an update. Ellomay Capital Ltd., a renewable energy company, has maintained its Baa1.il credit rating with a stable out...

Ellomay Capital Retains Stable Credit Outlook

Ellomay (ELLO) has released an update. Ellomay Capital Ltd. reports that Dorad Energy Ltd., in which it holds an indirect 9.4% stake, has published...

Ellomay Capital Shares Positive Dorad Energy Financials

Ellomay (ELLO) has released an update. Ellomay Capital Ltd. has reached a significant step forward in securing project finance for its 198 MW Solar...

Ellomay Capital Advances Solar Finance Deal in Italy

Ellomay (ELLO) has released an update. Ellomay Capital Ltd., a renewable energy company, announced the sale of Investment Tax Credits worth approxi...

Ellomay Capital Advances U.S. Solar Strategy

Ellomay (ELLO) has released an update. Ellomay Capital, the renewable energy firm, has reported a decrease in revenues and a shift from profit to l...

Ellomay Capital Experiences Financial Downturn in H1 2024

Ellomay GAAP EPS of $0.04, revenue of $11.2M

Ellomay (ELLO) has released an update. Ellomay Capital has secured commitments from Israeli investors for a private placement of its Series F Deben...

Ellomay Capital Secures NIS 62.2M in Debenture Placement

Ellomay (ELLO) has released an update. Ellomay has made significant strides in the renewable energy sector, with projects spanning Israel, the USA,...

Ellomay's Renewable Energy Expansion Across Key Markets

Ellomay (ELLO) has released an update. Ellomay Capital Ltd. has announced that an arbitrator has partially ruled against the appeals filed by both ...

Ellomay Capital Announces Arbitration Ruling Outcome

Press Releases

Ellomay Capital Announces the Filing of the Annual Report on Form 20-F for 2023

Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three Months Ended March 31, 2024

Ellomay Capital Announces Execution and Financial Closing of Project Finance for the Ellomay Solar Project and Consummation of Sale of the Talmei Yosef Project

Comments

Ellomay Cap

Ellomay Cap (ELLO) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga